Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125105142 | 12510514 | 2 | F | 20130628 | 20160923 | 20160629 | 20160928 | EXP | US-ENDO PHARMACEUTICALS INC.-2016-004237 | ENDO | 60.69 | YR | M | Y | 118.95000 | KG | 20160928 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125105142 | 12510514 | 1 | PS | TESTIM | TESTOSTERONE | 1 | Transdermal | 21454 | 50 | MG | GEL | QD | |||||||
| 125105142 | 12510514 | 2 | SS | AXIRON | TESTOSTERONE | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 125105142 | 12510514 | 3 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Unknown | U | 0 | UNKNOWN | /month | ||||||||
| 125105142 | 12510514 | 4 | C | ZETIA | EZETIMIBE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 5 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 6 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 7 | C | COREG | CARVEDILOL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 9 | C | CIALIS | TADALAFIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125105142 | 12510514 | 10 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125105142 | 12510514 | 1 | Androgen replacement therapy |
| 125105142 | 12510514 | 2 | Androgen replacement therapy |
| 125105142 | 12510514 | 3 | Androgen replacement therapy |
| 125105142 | 12510514 | 4 | Product used for unknown indication |
| 125105142 | 12510514 | 5 | Product used for unknown indication |
| 125105142 | 12510514 | 6 | Product used for unknown indication |
| 125105142 | 12510514 | 7 | Product used for unknown indication |
| 125105142 | 12510514 | 8 | Product used for unknown indication |
| 125105142 | 12510514 | 9 | Product used for unknown indication |
| 125105142 | 12510514 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125105142 | 12510514 | DS |
| 125105142 | 12510514 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125105142 | 12510514 | Cerebrovascular accident | |
| 125105142 | 12510514 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125105142 | 12510514 | 1 | 201305 | 201410 | 0 | |
| 125105142 | 12510514 | 2 | 201305 | 0 | ||
| 125105142 | 12510514 | 3 | 20120430 | 0 |